Prior Authorization Comparison
Cohere Health vs Humata Health: which AI prior authorization platform fits your 2026 workflow?
Cohere Health and Humata Health are both credible AI prior authorization vendors, but they approach the market from different buying angles. Cohere is the stronger default for health plans, delegated risk organizations, and provider networks that want clinical intelligence, utilization management collaboration, EHR integration, and CMS-0057-F API readiness. Humata is the stronger default for provider, pharmacy, and payer teams focused on frictionless prior authorization workflows across requirements discovery, submission support, statusing, audit trails, and clinical review.
Quick verdict
Choose Cohere Health if the buyer is a payer, delegated clinical organization, or provider network that needs a clinical intelligence platform across utilization management, provider collaboration, EHR integration, interoperability, CMS-0057-F readiness, and human clinical oversight.
Choose Humata Health if the buyer is trying to make day-to-day prior authorization work faster across providers, pharmacies, and payers, with emphasis on policy matching, submission support, automated statusing, analytics, audit trails, AI-driven clinical review, and medical or specialty-drug workflows.
The practical rule: Cohere is more platform-and-UM oriented; Humata is more frictionless prior authorization workflow oriented. Both require a careful integration and compliance review before purchase.
Cohere Health vs Humata Health comparison table
| Decision point | Cohere Health | Humata Health |
|---|---|---|
| Best fit | Health plans, delegated risk organizations, specialty management groups, and provider networks with clinical intelligence and UM modernization needs. | Provider, pharmacy, and payer teams trying to automate prior authorization across drugs, services, procedures, submissions, statusing, and review workflows. |
| Platform posture | Cohere Unify is presented as a clinical intelligence foundation for authorization, utilization management, payment integrity, and related workflows. | Humata presents itself around Frictionless Prior Authorization, policy matching, policy intelligence, submission support, statusing, analytics, and audit trails. |
| AI positioning | Clinical-grade precision AI, clinical decision support, unstructured clinical data extraction, and assistance when human input is required. | AI-driven policy matching, clinical bundling, smart attestation answering, clinical review, audit, and automation across the authorization lifecycle. |
| Interoperability | Public platform page references Epic, Rhyme, CMS-0057-F APIs, CRD, DTR, PAS, and a Cohere Connect option. | Public page emphasizes payer connectivity and connected provider/payer experiences; buyers should request exact API, EHR, clearinghouse, and payer-network details. |
| WISeR visibility | CMS lists Cohere Health as a WISeR participant; Cohere's own platform messaging emphasizes AI plus human oversight. | CMS lists Humata Health as a WISeR participant, and Humata's site includes WISeR provider resources for Oklahoma providers. |
| Compliance review | Ask for BAA terms, HIPAA controls, HITRUST/NCQA/URAC scope, role-based access, retention, encryption, audit logs, and reviewer accountability. | Ask for BAA terms, data handling, model logging, payer-specific audit trail behavior, human review workflow, and denial/appeal evidence capture. |
| Main buying risk | Overbuying an enterprise clinical intelligence platform when the immediate need is a narrow provider-side PA queue. | Assuming broad payer or CMS interoperability readiness without validating the exact modules, integrations, geographies, and use cases in contract. |
Where Cohere Health wins
Cohere Health wins when the prior authorization problem is a clinical collaboration and utilization management problem, not just a submission problem. Its public Cohere Unify page describes an AI-powered foundation for utilization management, payment integrity, and clinical workflows, with EHR integration, interoperability, human oversight, and clinical-grade AI assistance.
Cohere is also stronger when the technical buyer cares about CMS-0057-F and Da Vinci implementation-guide language. Cohere publicly states support for CRD, DTR, and PAS APIs aligned with HL7 Da Vinci guides, plus integrations such as Epic, Rhyme, and common portal technologies. That does not remove the need for diligence, but it gives technical evaluators clearer regulatory and interoperability hooks.
Where Humata Health wins
Humata Health wins when the buyer wants the prior authorization workflow itself to become easier across providers, pharmacies, and payers. Its site presents a broad set of capabilities around auth requirements, PolicyLink, AI-driven clinical bundling, PolicyMatch, policy intelligence, submission support, smart attestation answering, automated statusing, post-authorization monitoring, analytics, audit trails, AI-driven clinical review, intelligent gold-carding, and AI-driven audit.
Humata is especially attractive for provider-side teams that want to reduce manual portal work, missing documentation, and follow-up effort. It is also relevant for 2026 WISeR watchers because CMS lists Humata as a WISeR participant and Humata's site includes WISeR provider resources.
CMS WISeR context
CMS describes WISeR as an active model that uses enhanced technologies such as AI and machine learning along with human clinical review. CMS says it will run for six performance years, from January 1, 2026 through December 31, 2031, in New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. CMS lists six participants, including Cohere Health and Humata Health.
Do not treat WISeR participation as a universal product endorsement. Treat it as a signal that both vendors are visible in a Medicare review model where AI, human clinical review, service-specific rules, and provider experience matter. Buyers still need to validate the exact contracted workflow, geography, service categories, provider resources, appeal pathways, and audit controls.
Integration and API readiness
Cohere has the clearer public interoperability story, with references to EHR integration, Epic, Rhyme, CMS-0057-F APIs, CRD, DTR, PAS, portal access, and Cohere Connect. Humata has the clearer public workflow breadth story, with requirements discovery, policy matching, submission support, statusing, audit trails, and connected provider/payer experiences.
The evaluation should use your real transaction map: medical services, medical-benefit drugs, pharmacy-benefit drugs, payer portals, EHR workflows, clearinghouse transactions, attachments, status updates, denial reasons, appeal documentation, and public metrics. Ask both vendors to demonstrate the same three workflows against your environment instead of accepting a generic demo.
Security, HIPAA, and human review
Both vendors operate in a category where protected health information, medical necessity, and coverage decisions create high governance risk. Require BAA review, access controls, encryption details, retention terms, model-output logging, human reviewer attribution, audit trails, escalation rules, and incident-response language. Do not allow AI-generated recommendations to bypass clinical review where policy, regulation, or patient risk requires human judgment.
This point matters because CMS's Prior Authorization API FAQ says the 2024 final rule did not require real-time decisions, and some decisions will continue to need review and evaluation by clinical reviewers. AI should shorten avoidable administrative work without obscuring accountability.
Final recommendation
Pick Cohere Health if your buying committee includes payer operations, clinical policy, interoperability, and utilization-management leaders who need a governed platform foundation. Pick Humata Health if your primary pain is day-to-day prior authorization friction across providers, pharmacies, payers, submissions, statusing, and documentation.
If the decision is close, run a structured bakeoff. Use one high-volume routine procedure, one complex procedure, one specialty drug, one missing-documentation case, one denial, and one appeal. Score both vendors on accuracy, provider effort, reviewer effort, status visibility, API path, audit trail quality, and the amount of manual work left outside the system.
FAQ
Is Cohere Health better than Humata Health?
Cohere Health is usually better for payer, clinical intelligence, utilization management, and interoperability-heavy use cases. Humata Health is usually better when the buyer wants broad prior authorization workflow automation across providers, pharmacies, payers, and day-to-day submission operations.
Are Cohere Health and Humata Health WISeR vendors?
CMS lists both Cohere Health and Humata Health among WISeR model participants as of the CMS WISeR page checked on May 16, 2026. Buyers should still validate exactly which WISeR-related workflows apply to their geography and service category.
Which platform is better for provider-side teams?
Humata is the easier first shortlist for provider-side teams focused on submission support, statusing, and operational friction. Cohere can also fit provider networks, especially where payer collaboration, clinical intelligence, and EHR integration are central.
Which platform is better for payers?
Cohere is usually the stronger first shortlist for payer and UM modernization. Humata also serves payer workflows, so the final decision should be based on contracted modules, clinical-review workflow, integrations, and audit requirements.
Should buyers wait for CMS's 2026 proposed rule to become final?
No, but they should avoid overcommitting to unsupported compliance claims. Use the proposed rule as a readiness checklist around FHIR, API endpoints, usage metrics, denial reasons, drug authorization workflows, and decision timeframes while recognizing that proposals can change before finalization.